Mutations in NOD2 have been associated with granulomatous autoinflammatory conditions, including Blau syndrome (BS), inflammatory bowel disease (IBD), and NOD2-associated autoinflammatory disease (NAID) (4, 5). Here, NOD2 is linked to Blau syndrome.